{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:41Z","timestamp":1791218141939,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,30]]},"DOI":"10.1097\/qad.0b013e3282f09876","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T20:54:57Z","timestamp":1236200097000},"page":"2483-2491","source":"Crossref","is-referenced-by-count":105,"title":["Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa"],"prefix":"10.1097","volume":"21","author":[{"given":"Raoul","family":"Moh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Danel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8ne","family":"Messou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Ouassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Gabillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Anzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Abo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bissagnene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Seyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Eholi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Anglaret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.aids.0000226959.87471.01","article-title":"Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study","volume":"20","author":"Etard","year":"2006","journal-title":"AIDS"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/135965350300800505","article-title":"Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, C\u00f4te d'Ivoire","volume":"8","author":"Seyler","year":"2003","journal-title":"Antivir Ther"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/01.aids.0000191232.16111.f9","article-title":"Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(06)68887-9","article-title":"CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial","volume":"367","author":"Danel","year":"2006","journal-title":"Lancet"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.qai.0000219777.04927.50","article-title":"Tolerance and acceptability of an efavirenz-based regimen in 740 adults (Predominantly women) in West Africa","volume":"42","author":"Danel","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/135965350501000510","article-title":"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Cote d'Ivoire","volume":"10","author":"Moh","year":"2005","journal-title":"Antivir Ther"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/JCM.43.6.2709-2717.2005","article-title":"Transfer and evaluation of an automated, low-cost real-time reverse transcription \u2013 PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting","volume":"43","author":"Rouet","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00002030-200303070-00013","article-title":"Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Cote d'Ivoire","volume":"17","author":"Anglaret","year":"2003","journal-title":"AIDS"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis following antiretroviral treatment initiation in Abidjan","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(06)68580-2","article-title":"Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment","volume":"367","author":"Ferradini","year":"2006","journal-title":"Lancet"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.296.7.782","article-title":"Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes","volume":"296","author":"Stringer","year":"2006","journal-title":"JAMA"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00126334-200501010-00003","article-title":"Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults","volume":"38","author":"Laurent","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1097\/QAD.0b013e32801086b0","article-title":"Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi","volume":"20","author":"Zachariah","year":"2006","journal-title":"AIDS"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/01.aids.0000226957.79847.d6","article-title":"Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort","volume":"20","author":"Calmy","year":"2006","journal-title":"AIDS"},{"key":"R20-14-20210130","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(06)69118-6","article-title":"Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda","volume":"368","author":"Weidle","year":"2006","journal-title":"Lancet"},{"key":"R21-14-20210130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.qai.0000159668.80207.5b","article-title":"Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana","volume":"40","author":"Wester","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-14-20210130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200404090-00006","article-title":"Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa","volume":"18","author":"Coetzee","year":"2004","journal-title":"AIDS"},{"key":"R23-14-20210130","first-page":"2283","article-title":"CD4 count-guided interruption of antiretroviral treatment.","volume":"3556","year":"2006","journal-title":"N Engl J Med"},{"key":"R25-14-20210130","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study","volume":"368","author":"Badri","year":"2006","journal-title":"Lancet"},{"key":"R27-14-20210130","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda","volume":"364","author":"Mermin","year":"2004","journal-title":"Lancet"},{"key":"R28-14-20210130","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","article-title":"Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C\u00f4te d'Ivoire: a randomised trial","volume":"353","author":"Anglaret","year":"1999","journal-title":"Lancet"},{"key":"R29-14-20210130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/507095","article-title":"Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation","volume":"43","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R30-14-20210130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-140-4-200402170-00007","article-title":"The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy","volume":"140","author":"Anastos","year":"2004","journal-title":"Ann Intern Med"},{"key":"R32-14-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0035-9203(00)90306-7","article-title":"Relapse and recurrent tuberculosis in the context of a national tuberculosis control programme","volume":"94","author":"Harries","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R33-14-20210130","first-page":"409","article-title":"DOT or not? Direct observation of antituberculosis treatment and patient outcomes, Kerala State, India","volume":"4","author":"Balasubramanian","year":"2000","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200711300-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:21Z","timestamp":1786038261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200711300-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,30]]},"references-count":27,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f09876","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11,30]]}}}